Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer
Kees Hendricksen, Antoine G. van der Heijden, Erik B. Cornel, Henk Vergunst, Theo M. de Reijke, Erika van Boven, Geert A. H. J. Smits, Rajiv Puri, Sigrid Gruijs, J. Alfred WitjesТом:
27
Мова:
english
Сторінки:
6
DOI:
10.1007/s00345-009-0382-4
Date:
June, 2009
Файл:
PDF, 286 KB
english, 2009